Stay updated on Nivolumab +/- Ipilimumab in Oral Cavity Squamous Cell Clinical Trial
Sign up to get notified when there's something new on the Nivolumab +/- Ipilimumab in Oral Cavity Squamous Cell Clinical Trial page.

Latest updates to the Nivolumab +/- Ipilimumab in Oral Cavity Squamous Cell Clinical Trial page
- Check4 days agoChange DetectedThe page now states that recruitment has ceased for participants and adds new guidance sections, while reorganizing the Intervention/Treatment content. It also includes a version update to Revision: v3.6.0, replacing the older v3.5.5 tag.SummaryDifference0.4%

- Check11 days agoChange DetectedRevision: v3.5.5 is now shown, indicating a site update; study details and navigation remain unchanged.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedNew page revision v3.5.4 was published, replacing the prior v3.5.3. This marks a minor update to the page version, with no apparent changes to the study content.SummaryDifference0.1%

- Check54 days agoChange DetectedThis updates the ClinicalTrials.gov page’s displayed release/revision version from v3.5.2 to v3.5.3 without changing the study details.SummaryDifference0.1%

- Check61 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check90 days agoChange DetectedPage revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Nivolumab +/- Ipilimumab in Oral Cavity Squamous Cell Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab +/- Ipilimumab in Oral Cavity Squamous Cell Clinical Trial page.